DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20163207

Comparison of efficacy and safety of adapalene and benzoyl peroxide-clindamycin combination in the topical treatment of acne vulgaris

Anuradha Dubey, Hanmant Amane

Abstract


Background: Acne vulgaris is a dermatological disorder characterised by formation of comedones and inflammatory lesions. The treatment of acne basically involves reduction of lesions and prevention of permanent scarring. The current line of treatment for mild to moderate acne is topical medications with antimicrobials and retinoids. The present study assessed the efficacy and safety of adapalene in comparison to benzoyl peroxide-clindamycin combination that whether it is better than the benzoyl peroxide-clindamycin combination for topical treatment of mild to moderate acne vulgaris.

Methods: In this study, the patients with mild to moderate acne vulgaris were divided into two groups, one group was treated with topical adapalene whereas topical benzoyl peroxide-clindamycin combination was given to the other group. Assessment of efficacy was done by total lesion counting while safety assessment was done by noting the adverse drug reactions due to medication, the results were compared  at the end of 1, 2 and 3 months with the baseline values.

Results: At the end of this study, it was found that the reduction of non-inflammatory, inflammatory and total lesion counts from baseline were highly significant in both the groups (p<0.0001), but between the groups, differences were not significant statistically (p>0.05), therefore adapalene and benzoyl peroxide-clindamycin combination were found to have similar efficacy. The tolerability profile of adapalene was comparatively better than benzoyl peroxide-clindamycin combination.

Conclusions: Adapalene is as efficacious as benzoyl peroxide-clindamycin combination to treat mild to moderate acne vulgaris, but it is comparatively better tolerated than benzoyl peroxide-clindamycin combination.


Keywords


Pilo-sebaceous unit, Comedones, Antimicrobials, Retinoids

Full Text:

PDF

References


Emil A. Tanghetti. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6:27-35.

Selway J. The psychosocial impact of acne and rosacea. Adv Stud Nurs. 2005;3:239-43.

Reddy NB, Nandimath MK. Comparison of clinical efficacy of topical clindamycin with adapalene and adapalene alone in treatment of mild to moderate facial acne vulgaris. Int J Pharm Bio Sci. 2013;4:1079-88.

Rathi SK. Acne vulgaris treatment: The current scenario. Indian J Dermatol. 2011;56:7-13.

Dutil M. Benzoyl peroxide: enhancing antibiotic efficacy in acne management. Skin Therapy Lett. 2010;15:5-7.

Persy SH. Safety and efficacy of adapalene gel 0.1% in acne vulgaris: results of a post-marketing surveillance study. Indian J Dermatol Venereol Leprol. 2003;69:277-80.

Balaji A, Kumari R, Thappa DM. Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol. 2009;75:323-6.

Choudhury S, Chatterjee S, Sarkar DK, Dutta RN. Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: a randomized controlled trial. Indian J Pharmacol. 2011;43:628-31.

Ray C, Trivedi P, Sharma V. Acne and its treatment lines. Int J Res Pharma Bio. 2013;3:1-16.

Kraft J, Freiman A. Management of acne. CMAJ. 2011;183:E430-435.

Jain GK, Ahmed FJ. Adapalene pretreatment increases follicular penetration of clindamycin: In vitro and in vivo studies. Indian J Dermatol Venereol Leprol. 2007;73:326-9.

Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, et al. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Indian J Dermatolo Venereol Leprol. 2012;78:459-67.

Cunliffe WJ, Danby FW, Dunlap F, Gold MH, Gratton D, Greenspan A. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol. 2002;12:350-4.

Toole JW, Lockhart L, Potrebka J, Bowman JP, Novack GD. Comparative irritancy study among retinoid creams and gels. J Cutan Med Surg. 1999;3:298-301.

Egan N, Loesche C, Baker M. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68:20-4.

Ioannides D, Reigopoulos D, Katsambas A. Topical adapalene gel 0.1% versus. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. Br J Dermatol. 2002;147:523-7.

Ghoshal L, Banerjee S, Ghosh SK, Gangopadhyay DN, Jana S. Comparative evaluation of effectiveness of adapalene and azithromycin, alone or in combination, in acne vulgaris. Indian J Dermatol. 2007;52:179-83.

Langner A, Chu A, Goulden V, Ambroziak M. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Br J Dermatol. 2008;158:122-9.